Latest Opioid Stories
- Rapid and effective relief for all racehorses in study MELBOURNE, Australia, May 21, 2014 /PRNewswire/ -- A Phosphagenics Limited (ASX:POH, OTCQX: PPGNY) study using its TPM(®)/Oxycodone
A comparatively new form of a medication for alcohol and opioid dependence that’s injected once a month instead of taken orally once a day appears to be significantly more effective than some other medications – because more patients actually continue the prescribed regimen.
researchers from the University of Pennsylvania have led an effort to create an artificial chemical sensor based on one of the human body’s most important receptors, one that is critical in the action of painkillers and anesthetics.
Workers’ compensation claims professionals can gain a practical understanding of how changes in the central nervous system can affect the brain’s perception of pain and set the stage for chronic
JUPITER, Fla., May 8, 2014 /PRNewswire/ -- Charleston Laboratories, Inc., an emerging specialty pharmaceutical company focused on the research and development of novel pain products, today announced
JUPITER, Fla., May 2, 2014 /PRNewswire/ -- Charleston Laboratories, Inc., an emerging specialty pharmaceutical company focused on the research and development of novel pain products, today announced
REDWOOD CITY, Calif., May 1, 2014 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc.
Patent Protection for KP511 Extends KemPharm's Intellectual Property Estate for Leading Franchise of Abuse-Deterrent Opioid Medications CORALVILLE, Iowa, April 30, 2014 /PRNewswire/
Data from Clinical Drug-liking Studies Also to be Presented at APS Today STAMFORD, Conn., April 30, 2014 /PRNewswire/ -- Purdue Pharma L.P.
LONDON, April 29, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
- totally perplexed and mixed up.